Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2022-04-21 | Dr. Trenschel received an M.P.H. from Florida International University and a Doctor of Osteopathic Medicine from Nova Southeastern University College of Osteopathic Medicine. |
| 2022-08-31 | Robert J. Trenschel, D.O. ... In accordance with the merger transaction with Seneca Biopharma, Inc. ("Seneca") effected April 27, 2021, the board of directors of Seneca (the "Seneca Board") appointed Thomas Hallam, Ph.D., James R. Neal, Stephanie Diaz, Robert J. Trenschel, D.O. and Don Williams to the Board. |
| 2022-08-31 | Robert J. Trenschel, D.O. |
| 2023-04-21 | Dr. Trenschel received an M.P.H. from Florida International University and a Doctor of Osteopathic Medicine from Nova Southeastern University College of Osteopathic Medicine. |
| 2024-02-06 | Robert J. Trenschel, D.O.(10) Includes (i) 1,282 shares of common stock underlying stock options held by Dr. Trenschel and (ii) (a) 36,287 shares of common stock and (ii) 8,737 shares of common stock that may be acquired within 60 days pursuant to the exercise of outstanding warrants held by Yuma Regional Medical Center. |
Data sourced from SEC filings. Last updated: 2026-03-09